1762Chunghwa Chemical Synthesis & Biotech1762 info
-info-24h
Global rank
Market cap$0
Change 7d-
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Stock data
    Business data

      Chunghwa Chemical Synthesis & Biotech (1762) Stock Overview

      Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.

      1762 Stock Information

      Symbol
      1762
      Address
      No.1, Dongxing StreetNew Taipei City, 23850Taiwan
      Founded
      -
      Trading hours
      -
      Website
      https://www.ccsb.com.tw
      Country
      🇹🇼 Taiwan
      Phone Number
      886 2 8684 3318

      Chunghwa Chemical Synthesis & Biotech (1762) Price Chart

      -
      Value:-

      Chunghwa Chemical Synthesis & Biotech Overview: Key Details and Summary

      Stock data
      2024
      Change
      Shares Outstanding
      77.56M
      N/A
      Employees
      0
      N/A
      logo
      Facebook Icon
      Twitter Icon
      Linkedin Icon
      © 2024 Topstocks.org